Activation of SARS-CoV-2 neutralizing antibody is slower than elevation of spike-specific IgG, IgM, and nucleocapsid-specific IgG antibodies

Activation of SARS-CoV-2 neutralizing antibody is slower than elevation of spike-specific IgG, IgM, and nucleocapsid-specific IgG antibodies

Abstract COVID-19 antibody testing has been developed to investigate humoral immune response in SARS-CoV-2 infection. To assess the serological dynamics and neutralizing potency following SARS-CoV-2 infection, we investigated the neutralizing (NT) antibody, anti-spike, and anti-nucleocapsid antibodi...

Full description

Bibliographic Details
Main Authors: Maika Takahashi, Tomohiko Ai, Konomi Sinozuka, Yuna Baba, Gene Igawa, Shuko Nojiri, Takamasa Yamamoto, Maiko Yuri, Satomi Takei, Kaori Saito, Yuki Horiuchi, Takayuki Kanno, Minoru Tobiume, Abdullah Khasawneh, Faith Jessica Paran, Makoto Hiki, Mitsuru Wakita, Takashi Miida, Tadaki Suzuki, Atsushi Okuzawa, Kazuhisa Takahashi, Toshio Naito, Yoko Tabe
Format: Article
Language:English
Published: Nature Portfolio 2022-09-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-022-19073-z

Internet

https://doi.org/10.1038/s41598-022-19073-z

Similar Items